In the present study, we investigated the possible mechanisms involved in its regulation and extended molecular and immuno-pathological analyses to a greater number of PC samples (from a new cohort of patients) to find out whether SOX2 expression may be related to the patient's clinical pathological characteristics and follow-ups. Here, SOX2 is linked to pachyonychia congenita.